Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 219

1.

Physicochemical Stability of Monoclonal Antibodies: A Review.

Le Basle Y, Chennell P, Tokhadze N, Astier A, Sautou V.

J Pharm Sci. 2020 Jan;109(1):169-190. doi: 10.1016/j.xphs.2019.08.009. Epub 2019 Aug 26. Review.

PMID:
31465737
2.

A Negative Feedback Loop Regulates Integrin Inactivation and Promotes Neutrophil Recruitment to Inflammatory Sites.

McCormick B, Craig HE, Chu JY, Carlin LM, Canel M, Wollweber F, Toivakka M, Michael M, Astier AL, Norton L, Lilja J, Felton JM, Sasaki T, Ivaska J, Hers I, Dransfield I, Rossi AG, Vermeren S.

J Immunol. 2019 Sep 15;203(6):1579-1588. doi: 10.4049/jimmunol.1900443. Epub 2019 Aug 19.

3.

The anthelmintic drug praziquantel promotes human Tr1 differentiation.

Eyoh E, McCallum P, Killick J, Amanfo S, Mutapi F, Astier AL.

Immunol Cell Biol. 2019 May;97(5):512-518. doi: 10.1111/imcb.12229. Epub 2019 Jan 30.

PMID:
30623486
4.

[The impact of POP (Publish Or Perish) culture on pharmaceutical journals].

Guérin A, Astier A.

Ann Pharm Fr. 2018 Nov;76(6):419-420. doi: 10.1016/j.pharma.2018.10.001. French. No abstract available.

PMID:
30342568
5.

Impact of 3-week citrulline supplementation on postprandial protein metabolism in malnourished older patients: The Ciproage randomized controlled trial.

Bouillanne O, Melchior JC, Faure C, Paul M, Canouï-Poitrine F, Boirie Y, Chevenne D, Forasassi C, Guery E, Herbaud S, Le Corvoisier P, Neveux N, Nivet-Antoine V, Astier A, Raynaud-Simon A, Walrand S, Cynober L, Aussel C.

Clin Nutr. 2019 Apr;38(2):564-574. doi: 10.1016/j.clnu.2018.02.017. Epub 2018 Feb 21.

PMID:
29503060
6.

Anti-colchicine Fab fragments prevent lethal colchicine toxicity in a porcine model: a pharmacokinetic and clinical study.

Eddleston M, Fabresse N, Thompson A, Al Abdulla I, Gregson R, King T, Astier A, Baud FJ, Clutton RE, Alvarez JC.

Clin Toxicol (Phila). 2018 Aug;56(8):773-781. doi: 10.1080/15563650.2017.1422510. Epub 2018 Jan 15.

7.

[Annales pharmaceutiques françaises, a positive result].

Astier A.

Ann Pharm Fr. 2018 Jan;76(1):1-2. doi: 10.1016/j.pharma.2017.12.004. French. No abstract available.

PMID:
29287732
8.

TCR-stimulated changes in cell surface CD46 expression generate type 1 regulatory T cells.

Ni Choileain S, Hay J, Thomas J, Williams A, Vermeren MM, Benezech C, Gomez-Salazar M, Hugues OR, Vermeren S, Howie SEM, Dransfield I, Astier AL.

Sci Signal. 2017 Oct 24;10(502). pii: eaah6163. doi: 10.1126/scisignal.aah6163.

PMID:
29066539
9.

HpARI Protein Secreted by a Helminth Parasite Suppresses Interleukin-33.

Osbourn M, Soares DC, Vacca F, Cohen ES, Scott IC, Gregory WF, Smyth DJ, Toivakka M, Kemter AM, le Bihan T, Wear M, Hoving D, Filbey KJ, Hewitson JP, Henderson H, Gonzàlez-Cìscar A, Errington C, Vermeren S, Astier AL, Wallace WA, Schwarze J, Ivens AC, Maizels RM, McSorley HJ.

Immunity. 2017 Oct 17;47(4):739-751.e5. doi: 10.1016/j.immuni.2017.09.015.

10.

Complement as a regulator of adaptive immunity.

Killick J, Morisse G, Sieger D, Astier AL.

Semin Immunopathol. 2018 Jan;40(1):37-48. doi: 10.1007/s00281-017-0644-y. Epub 2017 Aug 25. Review.

11.

Extended stability of the rituximab biosimilar CT-P10 in its opened vials and after dilution and storage in polyolefin bags.

Vieillard V, Paul M, Ibrahim T, Astier A.

Ann Pharm Fr. 2017 Nov;75(6):420-435. doi: 10.1016/j.pharma.2017.06.003. Epub 2017 Aug 4.

PMID:
28784243
12.

How to select a nanosimilar.

Astier A, Barton Pai A, Bissig M, Crommelin DJA, Flühmann B, Hecq JD, Knoeff J, Lipp HP, Morell-Baladrón A, Mühlebach S.

Ann N Y Acad Sci. 2017 Nov;1407(1):50-62. doi: 10.1111/nyas.13382. Epub 2017 Jul 17.

13.

Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper.

Aapro M, Astier A, Audisio R, Banks I, Bedossa P, Brain E, Cameron D, Casali P, Chiti A, De Mattos-Arruda L, Kelly D, Lacombe D, Nilsson PJ, Piccart M, Poortmans P, Riklund K, Saeter G, Schrappe M, Soffietti R, Travado L, van Poppel H, Wait S, Naredi P.

Eur J Cancer. 2017 Sep;82:193-202. doi: 10.1016/j.ejca.2017.04.014. Epub 2017 Jul 7.

14.

Nitric oxide induces human CLA+CD25+Foxp3+ regulatory T cells with skin-homing potential.

Yu C, Fitzpatrick A, Cong D, Yao C, Yoo J, Turnbull A, Schwarze J, Norval M, Howie SEM, Weller RB, Astier AL.

J Allergy Clin Immunol. 2017 Nov;140(5):1441-1444.e6. doi: 10.1016/j.jaci.2017.05.023. Epub 2017 Jun 7. No abstract available.

PMID:
28601680
15.

Prostaglandin E2 stimulates adaptive IL-22 production and promotes allergic contact dermatitis.

Robb CT, McSorley HJ, Lee J, Aoki T, Yu C, Crittenden S, Astier A, Felton JM, Parkinson N, Ayele A, Breyer RM, Anderton SM, Narumiya S, Rossi AG, Howie SE, Guttman-Yassky E, Weller RB, Yao C.

J Allergy Clin Immunol. 2018 Jan;141(1):152-162. doi: 10.1016/j.jaci.2017.04.045. Epub 2017 Jun 3.

16.

_{36}^{96}Kr_{60}-Low-Z Boundary of the Island of Deformation at N=60.

Dudouet J, Lemasson A, Duchêne G, Rejmund M, Clément E, Michelagnoli C, Didierjean F, Korichi A, Maquart G, Stezowski O, Lizarazo C, Pérez-Vidal RM, Andreoiu C, de Angelis G, Astier A, Delafosse C, Deloncle I, Dombradi Z, de France G, Gadea A, Gottardo A, Jacquot B, Jones P, Konstantinopoulos T, Kuti I, Le Blanc F, Lenzi SM, Li G, Lozeva R, Million B, Napoli DR, Navin A, Petrache CM, Pietralla N, Ralet D, Ramdhane M, Redon N, Schmitt C, Sohler D, Verney D, Barrientos D, Birkenbach B, Burrows I, Charles L, Collado J, Cullen DM, Désesquelles P, Domingo Pardo C, González V, Harkness-Brennan L, Hess H, Judson DS, Karolak M, Korten W, Labiche M, Ljungvall J, Menegazzo R, Mengoni D, Pullia A, Recchia F, Reiter P, Salsac MD, Sanchis E, Theisen C, Valiente-Dobón JJ, Zielińska M.

Phys Rev Lett. 2017 Apr 21;118(16):162501. doi: 10.1103/PhysRevLett.118.162501. Epub 2017 Apr 17.

17.

[Flu vaccination by community pharmacists].

Astier A.

Ann Pharm Fr. 2017 Jan;75(1):1-2. doi: 10.1016/j.pharma.2016.12.002. French. No abstract available.

PMID:
28048980
18.

One-month stability study of a biosimilar of infliximab (Remsima®) after dilution and storage at 4°C and 25°C.

Vieillard V, Astier A, Sauzay C, Paul M.

Ann Pharm Fr. 2017 Jan;75(1):17-29. doi: 10.1016/j.pharma.2016.08.002. Epub 2016 Sep 19.

PMID:
27659414
19.

[Evaluation of professional practices: Implication of hospital pharmacist in improving care for vulnerable patients].

Bataille J, Bardo-Brouard P, Cordonnier-Jourdin C, Kini-Matondo W, Simpelaere S, Astier A, Paul M.

Ann Pharm Fr. 2017 Mar;75(2):121-130. doi: 10.1016/j.pharma.2016.06.003. Epub 2016 Jul 15. French.

PMID:
27423186
20.

Preclinical safety, pharmacokinetics, pharmacodynamics, and biodistribution studies with Ad35K++ protein: a novel rituximab cotherapeutic.

Richter M, Yumul R, Saydaminova K, Wang H, Gough M, Baldessari A, Cattaneo R, Lee F, Wang CH, Jang H, Astier A, Gopal A, Carter D, Lieber A.

Mol Ther Methods Clin Dev. 2016 Mar 30;5:16013. doi: 10.1038/mtm.2016.13. eCollection 2016.

21.

Implementation of automated dispensing cabinets for management of medical devices in an intensive care unit: organisational and financial impact.

Bourcier E, Madelaine S, Archer V, Kramp F, Paul M, Astier A.

Eur J Hosp Pharm. 2016 Mar;23(2):86-90. doi: 10.1136/ejhpharm-2014-000604. Epub 2015 Sep 8.

22.

Stability of ipilimumab in its original vial after opening allows its use for at least 4 weeks and facilitates pooling of residues.

Bardo-Brouard P, Vieillard V, Shekarian T, Marabelle A, Astier A, Paul M.

Eur J Cancer. 2016 May;58:8-16. doi: 10.1016/j.ejca.2016.01.008. Epub 2016 Feb 23.

PMID:
26922168
23.

[Emile Clément Jungfleisch, pharmacist and chemist (1839-1916)].

Astier A.

Ann Pharm Fr. 2016 Jan;74(1):1-2. doi: 10.1016/j.pharma.2015.12.002. French. No abstract available.

PMID:
26767848
24.

Editorial: T cell regulation by the environment.

Hafler DA, Astier AL.

Front Immunol. 2015 May 13;6:229. doi: 10.3389/fimmu.2015.00229. eCollection 2015. No abstract available.

25.

[Study impacto: Descriptive analyzis of pharmacist's clinical practice in onco-hematology].

Le Guen R, Madelaine I, Tournamille JF, Bellanger A, Astier A, Braguer D, Ollivier C, Bardin C, Lemare F, Daouphars M, Pinguet F, Latour JF, Vigneron J, Tilleul P.

Ann Pharm Fr. 2015 May;73(3):223-8. doi: 10.1016/j.pharma.2014.10.002. Epub 2014 Nov 12. French.

PMID:
25934530
26.

Monocyte:T-cell interaction regulates human T-cell activation through a CD28/CD46 crosstalk.

Charron L, Doctrinal A, Ni Choileain S, Astier AL.

Immunol Cell Biol. 2015 Oct;93(9):796-803. doi: 10.1038/icb.2015.42. Epub 2015 Mar 19.

27.

[The Annales: a sustained growth].

Astier A.

Ann Pharm Fr. 2015 Mar;73(2):85-6. doi: 10.1016/j.pharma.2015.02.003. French. No abstract available.

PMID:
25745941
28.

[Nicolas Lemery, apothicary and chemist].

Astier A.

Ann Pharm Fr. 2015 Jan;73(1):1-2. doi: 10.1016/j.pharma.2014.12.003. French. No abstract available.

PMID:
25577011
29.

Recombinant Ad35 adenoviral proteins as potent modulators of human T cell activation.

Hay J, Carter D, Lieber A, Astier AL.

Immunology. 2014 Sep 22. doi: 10.1111/imm.12391. [Epub ahead of print]

30.

Still a long way to go to achieve multidisciplinarity for the benefit of patients: commentary on the ESMO position paper (Annals of Oncology 25(1): 9-15, 2014).

Valentini V, Abrahamsson PA, Aranda SK, Astier A, Audisio RA, Boniol M, Bonomo L, Brunelli A, Bultz B, Chiti A, De Lorenzo F, Eriksen JG, Goh V, Gospodarowicz MK, Grassi L, Kelly J, Kortmann RD, Kutluk T, Plate A, Poston G, Saarto T, Soffietti R, Torresin A, van Harten WH, Verzijlbergen JF, von Kalle C, Poortmans P.

Ann Oncol. 2014 Sep;25(9):1863-5. doi: 10.1093/annonc/mdu245. Epub 2014 Jul 10. No abstract available.

31.

Review of therapeutic drug monitoring of anticancer drugs part two--targeted therapies.

Widmer N, Bardin C, Chatelut E, Paci A, Beijnen J, Levêque D, Veal G, Astier A.

Eur J Cancer. 2014 Aug;50(12):2020-36. doi: 10.1016/j.ejca.2014.04.015. Epub 2014 Jun 10. Review.

PMID:
24928190
32.

Review of therapeutic drug monitoring of anticancer drugs part 1--cytotoxics.

Paci A, Veal G, Bardin C, Levêque D, Widmer N, Beijnen J, Astier A, Chatelut E.

Eur J Cancer. 2014 Aug;50(12):2010-9. doi: 10.1016/j.ejca.2014.04.014. Epub 2014 Jun 2. Review.

PMID:
24889915
33.

Therapeutic drug monitoring in cancer--are we missing a trick?

Bardin C, Veal G, Paci A, Chatelut E, Astier A, Levêque D, Widmer N, Beijnen J.

Eur J Cancer. 2014 Aug;50(12):2005-9. doi: 10.1016/j.ejca.2014.04.013. Epub 2014 May 27.

PMID:
24878063
34.

[More evidence in favor of generics!].

Astier A.

Ann Pharm Fr. 2014 May;72(3):141-2. doi: 10.1016/j.pharma.2014.04.004. French. No abstract available.

PMID:
24780828
35.

Implementation of real-time identification analysis and quantification of chemotherapies preparations with a Multispec(®) analyser.

Bazin C, Vieillard V, Astier A, Paul M.

Ann Pharm Fr. 2014 Jan;72(1):33-40. doi: 10.1016/j.pharma.2013.09.006. Epub 2013 Oct 26.

PMID:
24438667
36.

[From Louis-Nicolas Vauquelin to Frederick Sanger: a plea for analytical chemistry].

Astier A.

Ann Pharm Fr. 2014 Jan;72(1):1-2. doi: 10.1016/j.pharma.2013.12.005. French. No abstract available.

PMID:
24438662
37.

[Evaluation of ownership of an implantable medical device by patients].

Salles M, Amet D, Archer V, Elbaz N, Teiger E, Paul M, Astier A.

Ann Pharm Fr. 2013 Nov;71(6):423-8. doi: 10.1016/j.pharma.2013.06.004. Epub 2013 Oct 14. French.

PMID:
24206595
38.

SFPO and ESOP recommendations for the practical stability of anticancer drugs: an update.

Vigneron J, Astier A, Trittler R, Hecq JD, Daouphars M, Larsson I, Pourroy B, Pinguet F; French Society of Hospital Pharmacists; European Society of Oncology Pharmacists.

Ann Pharm Fr. 2013 Nov;71(6):376-89. doi: 10.1016/j.pharma.2013.06.002. Epub 2013 Aug 28.

PMID:
24206590
39.

Physicochemical stability study of a new Trimix formulation for treatment of erectile dysfunction.

Vieillard V, Eychenne N, Astier A, Yiou R, Deffaux C, Paul M.

Ann Pharm Fr. 2013 Sep;71(5):358-63. doi: 10.1016/j.pharma.2013.06.005. Epub 2013 Aug 21.

PMID:
24075706
40.

[Health economics: a major challenge for the pharmacist].

Astier A.

Ann Pharm Fr. 2013 Sep;71(5):275-6. doi: 10.1016/j.pharma.2013.09.003. French. No abstract available.

PMID:
24075696
41.

[Volatil biomarkers: a revolution?].

Astier A.

Ann Pharm Fr. 2013 Jul;71(4):201-2. doi: 10.1016/j.pharma.2013.06.003. French. No abstract available.

PMID:
23835017
42.

The antitumor effects of an arsthinol-cyclodextrin complex in a heterotopic mouse model of glioma.

Becherirat S, Lanhers MC, Socha M, Yemloul M, Astier A, Loboda C, Aniceto N, Gibaud S.

Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):560-8. doi: 10.1016/j.ejpb.2013.06.021. Epub 2013 Jul 4.

PMID:
23831266
43.

Characterization of mitotane (o,p'-DDD)--cyclodextrin inclusion complexes: phase-solubility method and NMR.

Alfonsi R, Attivi D, Astier A, Socha M, Morice S, Gibaud S.

Ann Pharm Fr. 2013 May;71(3):186-92. doi: 10.1016/j.pharma.2013.02.001. Epub 2013 Mar 15.

PMID:
23622697
44.

Long-term physico-chemical stability of diluted trastuzumab.

Paul M, Vieillard V, Da Silva Lemos R, Escalup L, Astier A.

Int J Pharm. 2013 May 1;448(1):101-4. doi: 10.1016/j.ijpharm.2013.02.039. Epub 2013 Mar 4.

PMID:
23467078
45.

Calcitriol modulates the CD46 pathway in T cells.

Kickler K, Ni Choileain S, Williams A, Richards A, Astier AL.

PLoS One. 2012;7(10):e48486. doi: 10.1371/journal.pone.0048486. Epub 2012 Oct 29.

46.

[The scientific fraud in the medical domain].

Astier A.

Ann Pharm Fr. 2012 Sep;70(5):245-8. doi: 10.1016/j.pharma.2012.09.003. French. No abstract available.

PMID:
23020914
47.

[For an evidence-based pharmacy].

Astier A.

Ann Pharm Fr. 2012 Jul;70(4):179-81. doi: 10.1016/j.pharma.2012.07.002. French. No abstract available.

PMID:
22818258
48.

Long-term stability of diluted solutions of the monoclonal antibody rituximab.

Paul M, Vieillard V, Jaccoulet E, Astier A.

Int J Pharm. 2012 Oct 15;436(1-2):282-90. doi: 10.1016/j.ijpharm.2012.06.063. Epub 2012 Jul 10.

PMID:
22789912
49.

Long-term stability of bevacizumab repackaged in 1mL polypropylene syringes for intravitreal administration.

Paul M, Vieillard V, Roumi E, Cauvin A, Despiau MC, Laurent M, Astier A.

Ann Pharm Fr. 2012 May;70(3):139-54. doi: 10.1016/j.pharma.2012.03.006. Epub 2012 May 11.

PMID:
22655582
50.

[International opening of our Academy].

Astier A.

Ann Pharm Fr. 2012 May;70(3):119. doi: 10.1016/j.pharma.2012.05.001. French. No abstract available.

PMID:
22655579

Supplemental Content

Loading ...
Support Center